Spättoxizität und Survivorship bei Keimzelltumoren
Standard
Spättoxizität und Survivorship bei Keimzelltumoren. / Oechsle, K.; Schilling, G.; Oing, C.; Bokemeyer, C.
In: ONKOLOGE, Vol. 19, No. 7, 07.2013, p. 573-581.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Spättoxizität und Survivorship bei Keimzelltumoren
AU - Oechsle, K.
AU - Schilling, G.
AU - Oing, C.
AU - Bokemeyer, C.
N1 - Copyright: Copyright 2013 Elsevier B.V., All rights reserved.
PY - 2013/7
Y1 - 2013/7
N2 - Context. Germ cell tumors and Hodgkin's lymphoma are currently the malignant diseases with the highest cure rates. Even in advanced or metastasized disease stages these neoplasms can be cured by multimodal treatment approaches. Nevertheless, the curative treatment modalities applied, e.g. intensive systemic chemotherapy, radiotherapy and surgery, have side effects directly during the course of treatment and even delayed toxicity can occur, which may affect the health and quality of life of cancer survivors. This is why prevention and early detection as well as adequate treatment of toxic side effects affecting medical and psychosocial aspects are essential to maintain or improve patient quality of life.Material and methods. Research of literature and analysis of clinical trials.Results. Not only chronic dysfunction of many organ systems (e.g. cardiovascular risk) but also secondary cancer, infertility and the fear of relapse are common reasons for a variety of psychosocial problems which can prevent cancer survivors from living a normal daily life after curative treatment.Conclusion. Survivorship programs offer these patients the opportunity of dynamic support adapted to their needs on the way to patients becoming long-term survivors.
AB - Context. Germ cell tumors and Hodgkin's lymphoma are currently the malignant diseases with the highest cure rates. Even in advanced or metastasized disease stages these neoplasms can be cured by multimodal treatment approaches. Nevertheless, the curative treatment modalities applied, e.g. intensive systemic chemotherapy, radiotherapy and surgery, have side effects directly during the course of treatment and even delayed toxicity can occur, which may affect the health and quality of life of cancer survivors. This is why prevention and early detection as well as adequate treatment of toxic side effects affecting medical and psychosocial aspects are essential to maintain or improve patient quality of life.Material and methods. Research of literature and analysis of clinical trials.Results. Not only chronic dysfunction of many organ systems (e.g. cardiovascular risk) but also secondary cancer, infertility and the fear of relapse are common reasons for a variety of psychosocial problems which can prevent cancer survivors from living a normal daily life after curative treatment.Conclusion. Survivorship programs offer these patients the opportunity of dynamic support adapted to their needs on the way to patients becoming long-term survivors.
KW - Cardiovascular risk
KW - Germ cell cancer
KW - Late toxicity
KW - Recurrence
KW - Survivorship
UR - http://www.scopus.com/inward/record.url?scp=84887628472&partnerID=8YFLogxK
U2 - 10.1007/s00761-013-2472-6
DO - 10.1007/s00761-013-2472-6
M3 - SCORING: Zeitschriftenaufsatz
AN - SCOPUS:84887628472
VL - 19
SP - 573
EP - 581
JO - ONKOLOGE
JF - ONKOLOGE
SN - 0947-8965
IS - 7
ER -
